TSS
TARO

Two Sigma Securities’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Two Sigma Securities’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,153
Closed -$212K – 2963
2018
Q3 		$212K Buy
+2,153
New +$233K ﹤0.01% 2086
2016
Q4 		– Sell
-4,748
Closed -$525K – 999
2016
Q3 		$525K Buy
+4,748
New +$629K 0.18% 148

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

Two Sigma Securities's TARO Position: Q4 2018 in Review

Two Sigma Securities sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2018, closing a stake of 2,153 shares — an estimated $212K sold.

Two Sigma Securities first reported a position in TARO in Q3 2016 and held it in 2 quarters. The position peaked at $525K in Q3 2016. 94 funds tracked by Wall St. Rank hold TARO as of Q4 2018.

  • Two Sigma Securities reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2018 after selling out during the quarter.
  • Two Sigma Securities sold 2,153 Taro Pharmaceutical Industries Ltd. shares in Q4 2018, an estimated $212K.
  • Two Sigma Securities first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2016 and held it in 2 quarters.
  • Two Sigma Securities's Taro Pharmaceutical Industries Ltd. position peaked at $525K in Q3 2016.
  • 94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2018.

Based on Two Sigma Securities's 13F filing for Q4 2018, filed 14 Feb 2019.